According to Takeda Pharmaceutical's latest financial reports the company's total assets are $100.90 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-03-31 | $104.78 B | -2.97% |
2022-03-31 | $107.99 B | -7.74% |
2021-03-31 | $117.05 B | -1.36% |
2020-03-31 | $118.67 B | -4.5% |
2019-03-31 | $124.26 B | 221.71% |
2018-03-31 | $38.62 B | -0.67% |
2017-03-31 | $38.88 B | 14.27% |
2016-03-31 | $34.03 B | -4.93% |
2015-03-31 | $35.79 B | -19.39% |
2014-03-31 | $44.40 B | 3.32% |
2013-03-31 | $42.98 B | -1.23% |
2012-03-31 | $43.51 B | 29.86% |
2011-03-31 | $33.51 B | 11% |
2010-03-31 | $30.18 B | 8.25% |
2009-03-31 | $27.88 B | -2.27% |
2008-03-31 | $28.53 B | 9.37% |
2007-03-31 | $26.09 B | 0.99% |
2006-03-31 | $25.83 B | 8.74% |
2005-03-31 | $23.75 B | 6% |
2004-03-31 | $22.41 B | 28.44% |
2003-03-31 | $17.45 B | 18.38% |
2002-03-31 | $14.74 B | 6.82% |
2001-03-31 | $13.80 B |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $167.55 B | 66.05% | ๐บ๐ธ USA |
Novartis NVS | $99.94 B | -0.95% | ๐จ๐ญ Switzerland |
Pfizer PFE | $226.50 B | 124.47% | ๐บ๐ธ USA |
Amgen AMGN | $97.15 B | -3.72% | ๐บ๐ธ USA |
Sanofi SNY | $139.81 B | 38.56% | ๐ซ๐ท France |
Merck MRK | $106.67 B | 5.72% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $75.11 B | -25.56% | ๐ฌ๐ง UK |
Seagen
SGEN | $3.63 B | -96.40% | ๐บ๐ธ USA |
Dr. Reddy's RDY | $4.47 B | -95.56% | ๐ฎ๐ณ India |